Vision & strategy

Vision

Pharmacosmos aspires to be the leading pharmaceutical company in the research, manufacturing and marketing of intravenous iron infusion and iron injection pharmaceuticals.

Founded on extensive knowledge and expertise in carbohydrate polymers and iron carbohydrate complexes, Pharmacosmos envisions developing the new generation of intravenous iron infusion drug products for treatment of iron deficiency anemia.

Pharmacosmos will remain committed to carbohydrate manufacturing development. On a continuous basis, Pharmacosmos conducts and coordinates research activities, which investigate new clinical and technical applications of carbohydrate polymers, in particular dextran.

Finally, our goal is to maintain a strong awareness among academics, researchers and professionals of Pharmacosmos' foremost capacities in GMP manufacturing of carbohydrate polymers and iron carbohydrate complexes.

Strategy

Pharmacosmos aims to attract and hire the strongest candidates in the fields of biochemical engineering and processing, pharmaceutical development, administration and marketing. Our foundation for success is our employees' interest in and dedication towards developing our products and advancing our business.

Pharmacosmos' marketing strategy is to bring innovative products to worldwide markets by a combination of in-house marketing personnel and a global network of dedicated partners.

Pharmacosmos sustains intellectual property protection in regard to manufacturing technology, processing methods and drug product patents.

Learn more about our state-of-the-art facilities for manufacturing and development of treatments for iron deficiency anaemia.